Hypoglycaemia unawareness

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 3, 1997, Pages 29-35

  Bolli, G B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Hypoglycaemia prevention; Hypoglycaemia unawareness; Insulin dependent diabetes mellitus

Indexed keywords

BRAIN METABOLISM; COGNITION; CONFERENCE PAPER; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; UNCONSCIOUSNESS;

BRAIN; COGNITION DISORDERS; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPOGLYCEMIA; PERCEPTION; RECURRENCE;

EID: 0030763585     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Gerich J, Mokan M, Veneman T, Korytkowski M, Mitrakou A. Hypoglycemia unawareness. Endo Rev, 1991, 12, 356-371.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
3. Shade DS, Santiago JV, Skyler JS, Rizza RA. Intensive insulin therapy, Excerpta Medica, Amsterdam, 1983.
4. Pampanelli S, Fanelli C, Lalli C et al. Long-term intensive insulin therapy : effects of HbAlc, risk for severe and mild hypoglycaemia, status of counterregulation and unawareness of hypoglycaemia. Diabetologia, 1996, 39, 677-686.
5. Amiel S, Archibald H, Chusney G, Williams A, Gale E. Ketone infusion lowers hormonal responses to hypoglycaemia : evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci, 1991, 81, 189-194.
6. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlactacidemia on symptoms, cognitive dysfunction and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes, 1994, 43, 1311-1317.
7. Maran A, Cranston I, Lomas J, Macdonald I, Amiel S. Protection by lactate of cerebral function during hypoglycaemia. Lancet, 1994, 343, 16-20.
8. Fanelli C, Di Vincenzo A, Modarelli F et al. Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced neuroglycopenia in humans. Diabetologia, 1993, 36, 1191-1197.
9. Bolli GB. From physiology of glucose counterregulation to prevention of hypoglycaemia in Type 1 diabetes mellitus. Diab Nutr Metab, 1990, 3, 333-349.
10. Schwartz N, Clutter W, Shah S, Cryer P. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the thresholds for symptoms. J Clin Invest, 1987, 79, 777-781.
11. Mitrakou A, Ryan C, Veneman T et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol, 1991, 260, E67-E74.
12. Fanelli C, Pampanelli S, Epifano L et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in, hypoglycaemia in humans. Diabetologia, 1994, 37, 797-807.
13. Foster DW, Rubenstein AH. Hypoglycemia. In : Harrison's principles of internal medicine. Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (Eds.), McGraw-Hill, Inc., New York, 1991, p. 1759.
14. Young CW, Karam JH. Hypoglycemic disorders. In: Basic and clinical endocrinology. Greenspan FS (Ed.), Appleton & Lange, East Norwalk, CT, 1991, p. 651.
15. Brunetti P, Bolli GB. Pharmacokinetics and pharmacodynamics of insulin : relevance to the therapy of diabetes mellitus. Diab Nutr Metab, 1977, 10, 24-34.
16. Bolli GB, Dimitriadis GD, Pehling GB et al. Glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med, 1984 ; 310, 1706-1711.
17. Fanelli C, Pampanelli S, Epifano L et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of a rationale, intensive insulin therapy in IDDM. Diabetologia, 1994, 37, 1265-1276.
18. Mitrakou A, Fanelli C, Vencman T et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med, 1993, 329, 834-839.
19. Amiel S, Sherwin R, Simonson D, Tamborlane W. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes, 1988, 37, 901-907.
20. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia, 1995, 38, 1412-1418.
21. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes, 1993, 42, 1233-1237.
22. Mokan M, Mitrakou A, Veneman T, et al. Hypoglycemia unawareness in IDDM. Diabetes Care, 1994, 17, 1397-1403.
23. Hvidberg A, Fanelli CG, Hershey T, Cryer PE. Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Diabetes, 1996, 45, 1030-1036.
24. Fanelli C, Paramore D, Hershey T, Terkamp C, Craft S, Cryer P. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction the following morning in IDDM. Diabetes, 1996, 45 (suppl. 2) : 55A.
25. Fanelli C, Epifano L, Rambotti AM et al. Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with IDDM of short duration. Diabetes, 1993, 42, 1683-1689.
26. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet, 1994, 344, 283-287.
27. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes, 1994, 43, 1426-1434.
28. Heller S, Crycr P. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes, 1991, 40, 223-226.
29. Dagogo-Jack SE, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest, 1993, 91, 819-828.
30. Fanelli C, Pampanelli S, Lalli C, et al. Long-term intensive therapy of IDDM diabetic patients with clinically overt autonomic neuropathy : effects on awareness of, and counterregulation to, hypoglycemia. Diabetes, in press (May), 1997.
31. McCall A, Fixman L, Fleming, Tornheim K, Chick W, Ruderman NB. Chronic hypoglycemia increases brain glucose transport. Am J Physiol, 1986, 251, E442-E447.
32. McCall AL, Millington WR, Wurtman RJ. Metabolic fuel and aminoacid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci USA, 1982, 79, 5406-5410.
33. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA, 1994, 91, 9352-9356.
34. Boyle P, Kempers S, O'Connor AM, Nagy RJ. Brain glucose uptake and hypoglycemia unwareness in patients with insulin-dependent diabetes mellitus. N Engl J Med, 1995, 333, 1726-1731.
35. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest, 1996, 98, 680-691.
36. Dimitriadis C, Gerich J. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care, 1983, 6, 374-377.